Subscribe to RSS
DOI: 10.1055/s-0032-1326227
Self-expandable metal stents as definitive treatment for esophageal variceal bleeding
Publication History
submitted19 November 2012
accepted after revision17 December 2012
Publication Date:
06 March 2013 (online)
The use of self-expandable metal stents (SEMS) has occasionally been described for the treatment of uncontrollable esophageal variceal bleeding (EVB) as a bridge to an alternative treatment option (i. e. transjugular intrahepatic portosystemic shunt [TIPS]). It is currently not known whether SEMS placement is appropriate for more than temporary hemostasis. This case series report describes five patients in whom EVB could not be controlled with variceal band ligation and who were not suitable to undergo a TIPS procedure at the time of bleeding. SEMS were placed in these patients with the intent of definitive treatment. Successful initial hemostasis was achieved in all five patients, and sustained hemostasis occurred in four. Stents were removed from two patients after > 14 days and remained in situ until death in three other patients (range 6 – 214 days). No complications related to this longer duration were observed. In one case, TIPS could be performed at a later stage. SEMS could be a definitive treatment for uncontrollable esophageal bleeding in patients with a limited life expectancy or those unsuitable for TIPS at the time of bleeding.
-
References
- 1 Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010; 362: 823-832
- 2 Wright G, Lewis H, Hogan B et al. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc 2010; 71: 71-78
- 3 Hubmann R, Bodlaj G, Czompo M et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 2006; 38: 896-901
- 4 Maufa F, Al-Kawas FH. Role of self-expandable metal stents in acute variceal bleeding. Int J Hepatol 2012; 2012: 418369
- 5 Escorsell A, Bosch J. Self-expandable metal stents in the treatment of acute esophageal variceal bleeding. Gastroenterol Res Pract 2011; 2011: 910986
- 6 Garcia-Pagan JC, Caca K, Bureau C et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010; 362: 2370-2379
- 7 Zehetner J, Shamiyeh A, Wayand W et al. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc 2008; 22: 2149-2152
- 8 Lopera JE. Role of emergency transjugular intrahepatic portosystemic shunts. Semin Intervent Radiol 2005; 22: 253-265
- 9 Binmoeller KF, Borsatto R. Variceal bleeding and portal hypertension. Endoscopy 2000; 32: 189-199
- 10 Holster IL, Polinder S, Moelker A et al. A cost study of covered transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic treatment for secondary prevention of gastro-oesophageal variceal bleeding. Abstract no: Tu1059. Gastroenterology 2012; 142 : 734
- 11 Boyer TD, Haskal ZJ. AASLD practice guidelines: the role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension. Hepatology 2010; 51: 1-16 Available from: http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/TIPS%20Update%20Nov%202009.pdf
- 12 Dechene A, El Fouly AH, Bechmann LP et al. Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion 2012; 85: 185-191